ArticlePloS one2019

Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.

Hatem A Abuelizz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.